ExEm Foam Inc announced today that ExEm Foam (air polymer-type A intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics in the U.S.. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm Foam to assess whether there may be a blockage in the fallopian tubes in women…
We know, we know.. This isn’t exactly healthcare related, but we thought this was a cool product and we were thrilled to see the team behind NOVA H1 Audio Earrings blow past their Kickstarter goal within hours last week. Friends, have a look at the first clip-on earphones on the planet. The earrings are fully packed with the latest technology embedded in real…
Earlier this week Vax-Immune Diagnostics annoucned that it has received CE Mark approval for its first-in-class medical device, LabReady GBS. LabReady’s Group B Strep product is the first in Vax-Immune Diagnostics’ lineup of women’s health solutions that helps avoid life-threatening complications and expensive consequences for mothers and their babies. With CE Mark approval, LabReady is now available to European physicians, patients, and hospital systems. The brainchild…
Every day we get another note about yet another startup, accelerator or European investor eager to break into women’s health innovation. Without question: Femtech in Europe is on the rise and both investors and the media are finally starting to pay attention. And while all this new traction is exciting, there are some unique opportunities, but also challenges the local ecosystem will…
Menopause startups are on the rise – both in numbers and in terms of the capital and attention they attract. Today another company focused on menopausal women joins their ranks: LaMaria – A skincare brand that’s pro-you instead of anti-age. The DTC company was founded by OB-GYN Dr. Manuela Maria Vazquez who wanted to create a product specifically for women undergoing hormonal…
Today Nest Collaborative, the creator of the first virtual lactation consultation platform, announced a $2.1M seed round led by Altitude Ventures, a healthcare-focused venture capital fund to scale its offering. Other investors participating in the round include Bread and Butter Ventures, Wavemaker 360, Portfolia FemTech Fund II, Connecticut Innovations, Carnrite Ventures, and the Hustle Fund. “More than 3 million mothers in the…
Earlier today Evofem announced the launch of “Get Phexxi”, a national direct-to-consumer campaign aimed at broadening awareness of its non-hormonal, use-it-only-when-you-need-it birth control method, Phexxi Approved by the U.S. Food and Drug Administration (FDA) in May 2020, Phexxi is an innovative non-hormonal contraceptive method created for women. With 21 million women in the U.S. at risk for pregnancy who are NOT using hormonal contraception, the company feels the time is…
Ava, a digital healthcare company focused on women’s reproductive health, announced today it has received FDA clearance for its Ava Fertility Tracker, making it the first and only FDA-cleared fertility tracking wearable. A fertility tracking sensor bracelet and accompanying app, Ava Fertility Tracker is already the first and only wearable, machine learning device to aid women in ovulation prediction and facilitation of…
